People
OncoZenge partners with Pharmanovia for exclusive BupiZenge commercialization in EMENA regions
18 October 2024 - Pharmaceutical company OncoZenge AB (publ) (STO:ONCOZ) announced on Friday plans to partner with Pharmanovia for exclusive commercialization rights of BupiZenge in Europe, the Middle...
Viatris added to Forbes' World's Best Employers 2024 list
9 October 2024 - US-based global healthcare company Viatris Inc (NASDAQ: VTRS) announced on Tuesday that has been added to Forbes' list of World's Best Employers 2024.This is the fourth cons...
Rarity Health named finalist for 21st MM+M Rare Disease Agency of the Year
24 September 2024 - New Jersey-based healthcare communications agency Rarity Health announced on Monday that it has been named an agency finalist for the 21st MM+M Rare Disease Agency of the Year.MM+M...
AxoSim names new vice president of Sales and Marketing
18 September 2024 - AxoSim, a New Orleans-based life science company focused on neurological disease, announced on Tuesday that it has appointed Stuart Gibb as its new vice president of Sales and Mark...
Kyverna Therapeutics names new CEO and board member
17 September 2024 - California-based clinical-stage biopharmaceutical company Kyverna Therapeutics, Inc. (Nasdaq: KYTX) announced on Monday that it has named Warner Biddle as its new chief executive o...
Anervea.ai names new chief commercial officer and board member
17 September 2024 - US-based company that deals with AI-powered commercialisation solutions for the pharmaceutical, life sciences and biotech industries Anervea.ai announced on Monday that it has name...